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ABSTRACT 
 
Rice bran oil emulsion beverage is a functional food rich in antioxidants and beneficial 
for human health, particularly to prevent metabolic syndrome. Metabolic syndrome is 
defined by a waist circumference of > 90 cm and two additional criteria out of five, 
namely triglycerides (TG) > 150 mg/dL, HDL-C < 40 mg/dL, and/or 140/90 mmHg, 
blood pressure, and fasting blood sugar of 100 mg / dL.  This research aimed to 
examine the level of tumor necrosis factor-α (TNF-α) after the intervention of taking 
rice bran emulsion and determine the parameter shifted on metabolic syndrome. This 
study was a parallel-group, double-blind study with randomized controlled trials. The 
subjects were divided into two groups: treatment and control. The first group (n=19) 
received two glasses of rice bran emulsion per day for four weeks, while the control 
group (n=17) received two glasses of placebo per day for four weeks. Different intakes 
of fat, iron, and vitamin B1 were present in the control group before and after the 
intervention (p=0.05). The data were analyzed using independent T-test samples 
against differences for each group from before and after interventions. The formulation 
of rice bran emulsion was prepared using bran oil, water, sugar ester, CMC, sucralose, 
salt, and flavor. The study demonstrated that TNF-α levels in both groups decreased 
from 6.8 ± 7.3 to 4.7 ± 0.6 (pg/dL) but were not significant (p>0.05). Nutrition changes 
influenced the intakes of fat, iron, and vitamin B1 but did not influence metabolic 
syndrome parameters of the treatment group. The level of nutritional adequacy-fat, iron 
and vitamin B1 pre-and post-intervention in both groups were significantly different. In 
conclusion, the levels of serum TNF-α on the treatment group had a decrease than those 
in the control group; however, it is not significant. Further study needs to be done to 
verify this finding. 
 




 https://doi.org/10.18697/ajfand.98.19615  17743 
INTRODUCTION 
 
Recently, the overall number of obesity cases has increased, particularly in developing 
countries, along with lifestyle and diet changes with high energy accompanied by a 
lack of physical activity. Indonesia's nutritional problems have shifted from 
malnourishment and nutrient shortages to overweight or obesity. The prevalence of 
national obesity tended to increase based on basic health research data [1], including 
data in 2013. The proportion of male obesity with an index of body mass (BMI) > 25, 
aged 18, rose from 13.9% to 19.7%. Male obesity increased from 14.8% to 32.9%, 
while central abdominal obesity increased from 18.8% to 26.6% in males, and females 
increased by 8% [1]. 
 
The increased prevalence of obesity has led to an increase in the number of Non-
Communicable Disease (NCD) patients associated with insulin resistance, such as pre-
diabetes, impaired glucose tolerance, diabetes mellitus, hypertension, and heart disease.  
In individuals with obesity, increased intracellular free fatty acid causes uncoupling of 
mitochondria and β oxidation, resulting in increased compound-free radicals called 
reactive oxygen species (ROS) [2]. High-fat diet causes increased ROS production, 
resulting in increased production of adipocytokines, namely, increased production of 
individual biological molecules and decreased adiponectin production resulting in the 
development of metabolic syndrome [3]. 
 
Reaven [4] first introduced metabolic syndrome in 1988 as a complex disorder 
associated with multiple cardiovascular risk factors, with each component of the risk 
factors having the ability to induce the incident individually. Weight gain is a 
predisposing factor for two major metabolic syndrome components, namely obesity and 
insulin resistance. Increased central obesity must be prevented to avoid cardiovascular 
disease, particularly in people with a family history of type 2 diabetes mellitus 
(DMT2), hypertension, and coronary heart disease, or atherogenic dyslipidemia, such 
as low levels of  HDL-cholesterol (HDL-C) and hypertriglyceridemia [4,5]. 
 
High-density lipoprotein-C has molecules that may inhibit lipid oxidation. High-density 
lipid-cholesterol levels may decrease as a result of oxidative stress. Its capacity to 
remove cholesterol from peripheral tissues is inhibited by oxidative stress, such as 
excessive consumption of fat and carbohydrates, obesity, and increased inflammatory 
chronicity characterized by increased tumor necrosis factor (TNF- ). Therefore, 
maintenance must be either in the form of the quantity or quality of HDL-C. If it goes 
wrong, the cardiovascular disease develops [6,7]. 
 
Antioxidants in rice bran oil enhance the body's levels, potentially bringing a damper 
on ROS and oxidative stress. Antioxidants can reduce the oxidation status by adding 
electrons and capturing the redox homeostasis.  In this way, antioxidants can suppress 
the chain reactions of free radical formation and ultimately prevent damage from 
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There are currently plenty of functional food ingredients that contain bioactive 
compounds that are useful for improving body functions to prevent disease. Some 
studies have shown that bioactive compounds of fiber-containing fruits and vegetables 
rich in antioxidants benefit health. Gamma oryzanol is one of the bioactive compounds 
in functional foods. Oryzanol in rice bran oil has been scientifically proven to improve 
underlying cholesterol and serum LDL levels for obese people [6]. Scientific evidence 
suggests an antioxidant-rich diet can protect the body against inflammation and obesity 
in metabolic syndrome [9,10]. This research aims to study the diet and serum levels of 
TNF-α before and after the administration of rice bran oil emulsion. In addition, the 
metabolic syndrome parameters were determined as well. 
 
MATERIALS AND METHODS 
 
Research Design  
The study was a double-blind, randomized, placebo-controlled trial conducted in 
Mintohardjo Navy Hospital, Jakarta, Indonesia. 
 
Materials 
The formulation of rice bran emulsion was rice bran oil obtained from The Thai 
Company (Thailand) and sugar ester obtained from Bratachem, Indonesia, 
carboxymethyl cellulose (CMC), sucralose, salt, flavor, and water. The rice bran oil, 
water, sugar ester, and CMC were mixed for 30 minutes with a homogenizer at 2,000 
rpm. After incorporating flavor, sucralose and salt, the homogenizer stirred the mixture 
for 30 minutes at 2,000 rpm. The emulsion was pasteurized for 30 minutes at 30oC and 
then packaged into tightly closed bottles. The amount administered was equivalent to 
57.6 mg γ-oryzanol. 
 
Subjects 
Subjects were males with metabolic syndrome and a waist circumference ≥90 cm. The 
subjects were selected based on the criteria of metabolic syndrome by the International 
Diabetes Federation 2006, which are having a waist circumference > 90 cm and having 
two other criteria out of the five, namely triglycerides (TG) level > 150 mg/dL, HDL-C 
< 40 mg/dL, and/or 140/90 mmHg blood pressure and fasting blood sugar of >100 
mg/dL. Subjects were randomly divided into two groups; 19 people were included in 
the treatment group and 17 people for the control group. The two glasses of rice bran 
oil emulsion or placebo were administered to the subjects on a daily basis in the 
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Figure 1: Selection Flow of Subjects 
 
Ethical Approval 
Prior to data collection, each subject was given a general description of the research 
purpose and benefits as well as the confidentiality of all data. Subjects who fulfilled the 
criteria for inclusion and were willing to follow the research activities provided signed 
informed consent. The research was approved by the ethical research committee of the 
University of Indonesia's Research Ethics Committee of the Faculty of Medicine with 
ethical review number: 870/UN2.FI / ETIK/2014. 
 
Data Collection 
During the study, nutrition education covered the consumption pattern. The subject was 
required to fill in dietary questionnaires and provide information on abdomen 
circumference, weight loss, and height. Venous blood collected by a paramedic in 2016 
was used to evaluate the criteria for the metabolic syndrome. 
 
The quality control of the data was carried out by contacting the subject by telephone 
each week, calibration of measuring instruments, and the collection of blood by 
experts. Bodyweight was measured and venous blood collected for TNF-α analysis 
after four weeks. 
 
Serum analysis for TNF-α was undertaken at the University of Indonesia's Faculty of 
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Data Analysis 
Independent T-test was conducted to analyze the difference before and after the 
intervention in each group using the significance value (p=0.05). The data were not 
normally distributed, and the mean scores were analyzed using the Mann-Whitney test. 
 
RESULTS AND DISCUSSION 
 
Biochemical characteristics of the subjects based on the parameters of Metabolic 
Syndrome 
Seventy-eight percent of subjects had elevated concentrations of blood TAG (>150 
mg/dL), and 81.0 percent with low HDL-C (some 40 mg/dL) {Table 1}. Most subjects 
had glucose levels <100 mg/dL. Systolic blood pressure was largely in the normal 
category (≤120 mmHg), while the majority of the diastolic blood pressure above the 
normal category. 
 
Adequacy and nutrition intake levels of the control and treatment group 
Table 2 shows that there was a significant difference between the intake of fat, iron, 
and B1 vitamins before and after the intervention in the control group (p≤0.05). On the 
other hand, for the treatment group, there was no difference in nutrient intakes 
(p≥0.05). There was a significant difference between the nutritional adequacy of fat, 
iron, and B1 vitamins from before and after intervention in the control group with 
p≤0.05. There was no significant difference in nutritional adequacy levels from before 
and after the intervention for the treatment group with p≥0.05.   
 
The study of the intervention products against TNFα levels of serum 
The mean value of serum TNF-α levels in the control group before the intervention was 
lower than the treatment group (Table 2). After the intervention, the average levels of 
serum TNF-α in the treatment group were lower than those of the control group. The 
serum TNF-α levels between groups were not significant. 
 
Nutrition Characteristics of the subject 
The subject's features from the data suggest elevated concentrations of TG and diastolic 
stress, low concentrations of HDL-C, moderate levels of fasting blood sugar, and 
normal systolic blood pressure. All subjects had metabolic syndrome because they had 
≥90 cm waist circumference that became the primary determinant. Central obesity with 
a waist circumference of ≥90 cm can trigger glucose resistance in metabolic syndrome, 
which can lead to the occurrence of certain illnesses, such as hypertension, type 2 
diabetes, and coronary disease with increased body mass index and visceral fat [11]. 
Central obesity and visceral fat can induce proinflammatory adipokines, including the 
secretion of TNF-α, accompanied by a decrease in adiponectin [12]. It can contribute to 
an increase in the function of the heart pumping oxygen throughout the body, inducing 
stress [13]. 
 
There was no significant difference between the control and intervention groups in the 
nutritional intake of fat, iron, and vitamin B1, indicating that nutrition impacts did not 
influence the parameters treatment groups. Furthermore, this also indicates that the 
amount of dietary adequacy is adequate [1]. 
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The interplay of Rice Bran Emulsion at TNF-α level 
Rice bran emulsion may have played a part against TNF-α levels, although it was not 
significant. These levels suggest that an intake of two glasses of rice bran emulsion 
beverages per day with an average of 57.6 mg oryzanol might deter a respiratory 
syndrome and eventually avoid cardiac illness, but more research is needed. Rice bran 
oil comprises not only oryzanol but also polyunsaturated fatty acids (n-3 PUPA). The 
consumption of n-3 PUPA is beneficial for patients with inflammatory illnesses with 
declining serum concentrations of TNFα and IL-6 [14,15]. Trebble et al. [16] stated 
that the production of TNFα and IL-6 decreased with increasing intake of n-3 PUFA in 
healthy men. 
 
Acute inflammation in the body is related to cytokines, such as interleukin and C-
reactive protein. Cytokines stimulate the liver to form proteins called acute phase 
proteins, including C-reactive protein and complement. The acute inflammatory 
response is an early response against inflammation. In some circumstances, when the 
process of acute inflammation is ineffective, it will develop into a chronic condition. 
Chronic inflammation will recruit TNF-α Cytokines since TNF-α plays an important 
role at the onset of insulin resistance in obesity and metabolic syndrome [17]. The 
levels of serum TNF-α will be increased in the case of chronic inflammation [18]. This 
pathway arises in blood vessels induced by elevated concentrations of serum 
triacylglycerol and cholesterol and a cardiac illness may develop. 
 
Another study on inflammatory biomarkers in rats was conducted by Maigoda et al. 
[19] by administering food containing antioxidants. The findings of the study showed a 
decline in the inflammatory marker of TNF-α after the intervention. However, there 




Rice bran emulsion did not show significant cardiac protection in the metabolic 
syndrome compared with the control group, which is defined by the reduction in TNF-α 
serum levels owing to its rich antioxidant content. This study implies that rice bran 
emulsion administration is not recommended for a duration of one month. Further study 
with a larger sample should be carried out, and the period of administration extended. 
In addition, the effect of the formulation of ingredient preparation on the absorption of 
rice bran emulsion should also be clarified. The limitation of this study was the 
difficulty of finding obese people with metabolic syndrome.  
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Table 1: Biochemical characteristics of the subject regarding the parameters of 
the Metabolic Syndrome 
Variable  Cut off points  n (36 people) % Mean±SD 
TG (mg/dl) ≤ 150 8 22 217.3±106.8 
 > 150 28 78  
HDL (mg/dl) ≤ 40 29 81 33.5±7.1 
  > 40     7 19  
Glucose (mg/dl)    ≤ 100 21 58 93.3±31.1 
  > 100  15 42  
Systolic (mmHg)  ≤ 120    21 58 127.8±16.1 
  > 120 15 42  
Diastolic (mmHg)    ≤ 80  5 14 85.8±9.1 




Table 2: Intake and the level of adequacy of nutrients regarding a control and 
treatment group 
*Paired t-test (p<0.05) Recommended Dietary Allowance: RDA 
    Control 
p* 
Treatment p* 
    Before After Before After  
Energy (Kcal) Intake 1469±478.6 1618±405.3 0.19 1367±362.0 1397±317.2 0.741 
 % RDA 57 63  54 55  
Protein (g) Intake 43.5±19.2 51.5±15.4 0.06 41.0±9.2 45.5±9.6 0.114 
 % RDA 67 79 0.06 63 70  
fat (g) Intake 40.5±22.7 49.74±15.2 0.032* 37.2±14.1 39.9±12.3 0.409 
 % RDA 57 70 0.029* 53 56  
Carbohydrate (g) Intake 228.8±67.8 232.5±61.0 0.82 213.1±74.5 207.35±59.26 0.721 
 % RDA 60 61  56 54  
Calcium (mg) Intake 261.6±132.7 240.2±116.1 0.56 194.8±115.7 240.88±149.43 0.349 
 % RDA 26 24 0.56 19 24  
Phosphorus (mg) Intake 453.4±190.5 456.4±214.7 0.96 395.3±127.7 427.69±149.9 0.50 
 % RDA 302 304 0.96 264 285  
Iron (mg) Intake 7.8±3.3 10.8±4.1 0.00 8.9±4.1 9.74±3.97 0.48 
 % RDA 61 83 0.00 69 75  
Vitamin A (mcg) Intake 876.0±958.3 451.8±322.8 0.11 497.4±334.2 764.01±1192.4 0.35 
 % RDA 146 75  83 127  
Vitamin B1 (mg) Intake 0.7±0.5 1.2±0.8 0.02 88.0±0.6 1.01±0.82 0.59 
 % RDA 47 81  59 69  
Vitamin C (mg) Intake 27.5±25.3 22.8±23.9 0.63 22.6±26.8 32.13±31.74 0.36 
 % RDA 31 25 0.63 25 36  
PUFA (g) Intake 0.5±1.7 1.5±3.4 0.33 0.4±0.4 0.54±0.85 0.66 
 % RDA 3 8  2 3  
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Table 3: Average levels of serum TNF-α before and after the intervention 
Subject Group 





Control Group 6.6 ± 4.1 4.9 ± 0.9 -1.7 ± 4.3a 
Treatment Group 6.8 ± 7.3 4 .7 ± 0.6 -2.1 ± 7.1a 
Figures followed by the same letters in the different row showed no significant difference 
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